RNAGene and PharmAbcine collaborate to develop next-generation mRNA-based antibody therapeutics March 22, 2022
In vivo data show Evusheld retains neutralizing activity against Omicron SARS-CoV-2 BA.2 subvariant March 22, 2022
Chongqing Medical University compounds inhibit GST isozyme Mu, sensitize tumors to cisplatin in vivo March 22, 2022
PKMYT1 inhibitor RP-6306 for the treatment of aberrant DNA damage repair-driven cancers March 22, 2022
RSS